Two new alkaloids, Capparin A (1) and B (2), along with seven known compounds 6-methoxyindoline-2,3-dione (3), wogonin (4), oroxylin A (5), kaempferol (6), apigenin (7), quercetin (8) and luteolin (9), were isolated from the whole plant of Capparis himalayensis. Their structures have been established on the basis of spectral methods and the structure of 1 was confirmed by X-ray crystallographic analysis.
Capparis himalayensis belonging to Capparidaceae grows widely in Xinjiang Uygur Autonomous Region and Tibet of China. Its root barks, leaves and fruits are used for the treatment of rheumatism in traditional medicine. 1) Previous investigations have led to the isolation of different chemical components showing various bioactivities from the Capparis genus [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] while up to now, there is no report regarding chemical constituents of this species. In the present study, we attempted to find some bioactive components from Capparis himalayensis to support its development as a medicinal resource. This paper describes the isolation and structural elucidation of two new alkaloids 6-methoxyl-2Ј-(methylthio)-spiro[3H-indole-3,5Ј(4ЈH)thiazol]-2(1H)-one (1) and 6-methoxy-2-(methylthio)-1H-indole-3-carbaldehyde (2) from the ethanol extract of the plant along with seven known compounds. The known compounds were identified as 6-methoxyindoline-2,3-dione (3), 12) wogonin (4), 13) oroxylin A (5), 14) kaempferol (6), 15, 16) apigenin (7), 15, 16) quercetin (8) 15, 16) and luteolin (9) 15) by comparison of spectroscopic properties (MS, 1 H-NMR, 13 C-NMR, HMQC and HMBC). Among the known compounds, 3, 4, 5, 7, 9 were isolated from Capparis genus for the first time.
Results and Discussion
Compound 1 was obtained as yellow plates, and gave a positive reaction to dragendorff reagent. The molecular formula of 1 was determined to be C 12 C-NMR and EI-MS data strongly suggested the feature of spirobrassinin derivative. 17) According to the molecular formula and the structure of 1,2,4-trisubstituted benzene indicated in 1 H-NMR spectrum, a methoxyl was suggested located at C-5 or C-6. In the heteronuclear multiple bond connectivity (HMBC) spectrum ( was racemic while the specific rotation suggested that levorotary enantiomer was a little bit more than dextrorotary enantiomer. One possible explanation for contradictory fact is that the sample used for specific rotary determination is obtained before single crystal formation, which contains more levorotatory enantiomer than dectrorotatory enantiomer. However, the single crystal grew for single crystal X-ray diffraction study was a result of the combination of levorotary enantiomer and dextrorotary in a 1 : 1 ratio. Since 1 was too little to resolute the anantiomers, we will proceed with the study in our continuous work. Compound 2 was obtained as white amorphous powder. The molecular formula was determined to be C 11 (Fig. 3) , the correlations between H-1 (d H 12. suggested an aldehyde group connected with C-3, the correlation between H-12 (d H 2.66) and C-2 (d C 143.9) indicated a methylthio connected with C-2. Furthermore, the NEOSY spectrum confirmed the methylthio and the methoxy connected with C-2 and C-6, respectively by correlations of H-1/H-12, H-11/H-5 and H-11/H-7 (Fig. 4) . Thus compound 2 was identified as 6-methoxy-2-(methylthio)-1H-indole-3-carbaldehyde and all the 1 H and 13 C signals had been designed by 2D NMR. We named this compound Capparine B.
Experimental
General Experimenting Melting points were determined on FisherJohns and are uncorrected. UV spectra were taken on a Philips PYE Unican Pu 8800 Spectrophotometer. IR spectra were measured with a Nicolet 5700 of Thermo. NMR spectra were measured in DMSO-d 6 on a VARIAN INOVA 600 spectrometer with chemical shifts being represented in parts per million (ppm) and tetramethylsilane (TMS) as an internal standard. EI-MS and HR-EI-MS were measured on a Zabspec E spectrometer at an ionization voltage of 70 eV. The TLC and HPTLC employed precoated silica gel plates (Qingdao Haiyang Chem. Co., Ltd.). For the column chromatography, silica gel (Qingdao Haiyang) and Sephadex LH-20 (Pharmacia) were used. X-Ray crystallographic data collection for 1 was carried on a MAC DIP-2030K single crystal X-ray diffractometer.
Plant Material The plant of Capparis himalayensis was collected in Xinjiang Uygur Autonomous Region of China, in September, 2004 and identified by Doctor Guo-qiang Li. Voucher specimen (XC-04-0912) was deposited in the Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College.
Extraction and Isolation The air-dried plant material (18 kg) was powdered and extracted with 95% EtOH and 50% EtOH respectively. The alcohol extract were concentrated under reduced pressure and successively extracted with petroleum ether, CHCl 3 , EtOAC and n-BuOH. The CHCl 3 -soluble extract (60.8 g) was subjected to a silica gel column chromatography and eluted with petroleum ether/EtOAc (gradient, 1 : 0→0 : 1) to yield 26 fractions. Fr. 6-8 (3.7 g) were further separated with silica gel column using petroleum ether/EtOAc (gradient, 1 : 0→0 : 1) to yield 43 portions, and portion 27 was purified by Sephadex LH-20 to afford 4 (18 mg). Fr. 9-11 (1.5 g) were further separated with silica gel column using petroleum ether/EtOAc (gradient, 1 : 0→0 : 1) and Sephadex LH-20 to yield 2 (12 mg) and 5 (5 mg). Fr. 12-13 (5 g) were applied to silica gel column eluted with a gradient of petroleum ether/EtOAC and Sephadex LH-20 to give 1 (13 mg) and 3 (9 mg). EtOAC-soluble extract (116.3 g) was subjected to a silica gel column eluted with CHCl 3 /MeOH (gradient, 1 : 0→0 : 1) to yield 28 fractions. Fr. 9 (4 g) was further separated with silica gel using petroleum ether/actone (gradient, 1 : 0→0 : 1) and Sephadex LH-20 to yield 6 (14 mg) and 7 (23 mg). Fr. 10-11 were separated with Sephadex LH-20 to yield 8 (25 mg) and 9 (10 mg) respectively. Table 1 .
